[HTML][HTML] Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art

R Iezzi, M Pompili, A Posa, G Coppola… - World journal of …, 2016 - ncbi.nlm.nih.gov
In recent years, a combination of intervention therapies has been widely applied in the
treatment of hepatocellular carcinoma (HCC). One such combined strategy is based on the …

Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma

M Canale, P Ulivi, FG Foschi, E Scarpi… - Critical Reviews in …, 2018 - Elsevier
Radiofrequency ablation (RFA) is an effective local treatment for curative intent in patients
with cirrhosis of the liver and hepatocellular carcinoma (HCC) with diameter< 3 cm. Several …

[HTML][HTML] Radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) for patients with medium-to-large hepatocellular carcinoma: a …

W Liu, H Xu, X Ying, D Zhang, L Lai… - … Medical Journal of …, 2020 - ncbi.nlm.nih.gov
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE)
for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of …

Developments in predictive biomarkers for hepatocellular carcinoma therapy

A Casadei-Gardini, O Giulia, C Francesco… - Expert review of …, 2020 - Taylor & Francis
Introduction: Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver
and the third largest cause of cancer-relateddeaths worldwide. Potentially curative …

Efficacy and safety of combined radiofrequency ablation with transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage A hepatocellular …

AR Kim, E Park, SY Kwon, SJ Park… - The Korean Journal …, 2019 - synapse.koreamed.org
Background/Aims Surgical resection or ablation is recommended for the treatment of early
hepatocellular carcinoma (HCC), whereas transarterial chemoembolization (TACE) is …

[HTML][HTML] Radiological treatment of HCC: Interventional radiology at the heart of management

C Aubé, A Bouvier, J Lebigot, L Vervueren… - Diagnostic and …, 2015 - Elsevier
Interventional radiology is involved practically at each stage in the treatment of
hepatocellular carcinoma, as recommended in the EASL-EORTC guidelines. It is even …

[PDF][PDF] 索拉非尼联合免疫检查点抑制剂治疗TACE 抵抗的中晚期肝癌的疗效及安全性

吴徐璐, 陈炜越, 郑丽云, 方世记, 吴发宗… - 肝胆胰外科 …, 2021 - gdy.qk.wmu.edu.cn
目的探讨索拉非尼联合免疫检查点抑制剂(immune checkpoint inhibitors, ICIs)
治疗经肝动脉化疗栓塞术(transcatheter arterial chemoembolization, TACE) …

Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

C Dohi, K Nouso, K Miyahara, Y Morimoto… - Hepatology …, 2016 - Wiley Online Library
Aim Recurrence of hepatocellular carcinoma (HCC) is observed frequently, even after
curative treatments. The aim of this study is to elucidate the risk factors for recurrence of …

Local ablative procedures of the liver

CF Dietrich, XW Cui, L Chiorean… - Zeitschrift für …, 2015 - thieme-connect.com
Local ablative therapies have become an important part in the portfolio of treatment for
patients with malignant tumors especially in the liver. Although percutaneous ethanol …

Clinical effectiveness of transcatheter arterial chemoembolization sequential microwave ablation for lack of blood supply in hepatocellular carcinoma

J Chai, K Liu, D Lu, W Lv, S Chu, D Cheng, B Xu… - Future …, 2022 - Taylor & Francis
Aims: To determine the effectiveness and safety of sequential computed tomography-guided
percutaneous microwave ablation (MWA) after transcatheter arterial chemoembolization …